New NYU drug attacks cancer cells without harming healthy ones
The NYU Langone Health researchers and its Perlmutter Cancer Center developed a drug that reportedly eliminates cancer cells while maintaining healthy ones. It is an antibody that targets the mutant protein called HER2 without attacking normal ones. As a result, it can treat people without causing unintended health effects. READ: World’s first lung cancer vaccine
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.